Hu rau:Errol Zhou (Mr.)
Tel: ntxiv 86-551-65523315
Mobile/WhatsApp: ntxiv 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Email:sales@homesunshinepharma.com
Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj
CAS TSIS TAU: 2152628-33-4
Cov Qauv Nqaij: C29H31N7O3
Cov Nqa Molecular: 525.60200
EINECS TSIS MUAJ: 843-660-2
MDL TSIS TAU: NA
Khoom Qhia:
Khoom npe: selpercatinib CAS TSIS: 2152628-33-4
Txhais:
CPD2206;
SELPERCATINIB;
LOX-292;
Tshuaj& Cov Khoom Uas Lub Cev:
Zog: Dawb kom tawm cov khoom dawb dawb dawb
Ntsuas: ≥98.0%
Qhov ceev: 1.36 ± 0.1 g / cm3 (Teem Tau)
Kev Cia Cia: Qhuav, tsaus thiab nyob rau hauv 0 - 4 ℃ rau lub sij hawm luv luv (hnub mus rau lub lis piam) lossis -20 ℃ rau lub sijhawm ntev (hli txog xyoo).
Solubility: Soluble hauv DMSO
Cov Ntaub Ntawv Kev Nyab Xeeb:
Lub teeb liab lo lus: Nyab xeeb
Cov lus teev kev ceeb toom: H360 / 373
LOXO-292 (Selpercatinib, LOXO 292, LOXO292) yog qhov muaj zog, xaiv ua, muaj qhov ncauj RET kinase inhibitor nrog kev ua haujlwm antineoplastic. Selpercatinib (LOXO-292) yog ib qho RET kinase inhibitor. Selpercatinib qhia kev tiv thaiv qog ua kom zoo hauv lub hlwb thiab periphery hauv RET-kev mob qog ua qauv hauv vivo.
Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!
Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.
Cim npe nrov: selpercatinib cas 2152628-33-4, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag
